ロード中...
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease
Mitochondrial dysfunction, oxidative stress and neuroinflammation have been implicated as key mediators contributing to the progressive degeneration of dopaminergic neurons in Parkinson’s disease (PD). Currently, we lack a pharmacological agent that can intervene in all key pathological mechanisms,...
保存先:
| 出版年: | J Neuroimmune Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995106/ https://ncbi.nlm.nih.gov/pubmed/26838361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-016-9650-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|